SB 252 was crafted to bring long-overdue transparency to prescription drug pricing, ensure fair reimbursement for pharmacies, and rein in abusive PBM practices that have contributed to rising drug costs and the closure of community pharmacies across the state.
Live demonstration showcases Revionics’ commitment to push the boundaries in retail pricing innovation.
The company attributed the rise in identical sales primarily to strong growth in pharmacy sales.
Just in time for the 2025 NFL Draft, fans can score the ultimate SNICKERS duo in a game-time pack dubbed, the SNICKERS x Travis Hunter Two-Pack.
“AAM and the generics and biosimilars industry look forward to working with the Commerce Department and the White House to engage constructively on ways to incent more domestic investment in the medicines supply chain,” said John Murphy III, president and CEO.
This modern take on a timeless treat marks Kraft Heinz’s first foray into plant-based desserts.
Scholarships will help reduce financial barriers for student pharmacists.
Saves more than $800 million over 10 years; brings lower-cost medicines to patients soone
Amid growing anxieties, nearly 80% of shoppers feel in control of grocery spending, signaling resilience during economic uncertainty.
Retailers are encouraged to merchandise dietary support items near pharmacies, enhance digital shopping tools, and adapt packaging to highlight nutritional benefits clearly.
“We look forward to working collaboratively with FDA and other stakeholders on this important scientific and regulatory paradigm shift,” says the CHPA.
“The pullback we’ve seen the past few months comes despite strong economic fundamentals. A major factor appears to be driven by the uncertainty caused by tariffs,” NRF President and CEO Matthew Shay said.
Lawson succeeds William Ellis, who retired after 12 years of exemplary leadership as Executive Director of BPS.
Affordable family fun returns and new hospitality experience off 17th green debuts.
It’s uncertain whether tariffs will influence more companies to make more drugs in the U.S. like Trump is hoping for, some experts said.
